Delivery Order SPE2DB22D3016-SPE2DB25FBDV5
Award Date 8/1/25
Potential Completion Date 8/4/25
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Insulin Degludec Pen (U-200) 3ML with a ceiling value of $1,471.13. This contract, which was competitively awarded without set-aside designation, carries a firm fixed price structure and is categorized as a delivery order with an ultimate completion date of July 22, 2025. The award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Insulin Degludec Pen (U-100) 3ML with a ceiling value of $1,359.50. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set to be completed by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Insulin Degludec Pen (U-100) 3ML pharmaceutical products with a ceiling value of $1,157.57. This is a firm fixed-price delivery order with an ultimate completion date of July 22, 2025, and represents a child contract issued under a larger vehicle. The contract was awarded competitively without set-aside designation, and performance will be executed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Insulin Degludec Pen (U-200) 3ML with a ceiling value of $1,880.44. This firm fixed price contract, which is expected to be completed by August 28, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no set-aside designation, reflecting the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,156.40 to AmerisourceBergen Drug Corp for Insulin Degludec Pen (U-200) 3ML, a diabetes medication delivery system. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and was awarded on August 1, 2025. No set-aside designation was used in this competitive procurement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,471.35, is for the supply of Insulin Degludec Pen (U-200) 3ML, a critical medical commodity for federal healthcare programs. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,962.88 firm-fixed-price delivery order is for the supply of insulin degludec pens (U-200, 3mL) to support military healthcare programs. The contract has an ultimate completion date of January 31, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Department of Defense (DOD) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,184,917 units of Insulin Degludec Pens (U-200) 3ML. The contract, valued at $4,137.57, has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by the...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Insulin Degludec Pens (U-200) 3ML to the Department of Defense's Medical Supply Chain. The delivery order, valued at $2,111.78, is a firm fixed price contract with a performance period ending on March 21, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,125.39, is for the delivery of insulin degludec pens (U-200, 3ML) to support military healthcare programs. The contract has an ultimate completion date of October 29, 2024 and is structured as a firm fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen...